{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T06:26:42Z","timestamp":1775629602088,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T00:00:00Z","timestamp":1358121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Inhaled Bacillus anthracis spores germinate and the subsequent vegetative growth results in bacteremia and toxin production. Anthrax toxin is tripartite: the lethal factor and edema factor are enzymatic moieties, while the protective antigen (PA) binds to cell receptors and the enzymatic moieties. Antibiotics can control B. anthracis bacteremia, whereas raxibacumab binds PA and blocks lethal toxin effects. This study assessed plasma PA kinetics in rabbits following an inhaled B. anthracis spore challenge. Additionally, at 84 h post-challenge, 42% of challenged rabbits that had survived were treated with either levofloxacin\/placebo or levofloxacin\/raxibacumab. The profiles were modeled using a modified Gompertz\/second exponential growth phase model in untreated rabbits, with added monoexponential PA elimination in treated rabbits. Shorter survival times were related to a higher plateau and a faster increase in PA levels. PA elimination half-lives were 10 and 19 h for the levofloxacin\/placebo and levofloxacin\/raxibacumab groups, respectively, with the difference attributable to persistent circulating PA-raxibacumab complex. PA kinetics were similar between untreated and treated rabbits, with one exception: treated rabbits had a plateau phase nearly twice as long as that for untreated rabbits. Treated rabbits that succumbed to disease had higher plateau PA levels and shorter plateau duration than surviving treated rabbits.<\/jats:p>","DOI":"10.3390\/toxins5010120","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T02:36:29Z","timestamp":1358217389000},"page":"120-138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin\/ Raxibacumab-Treated New Zealand White Rabbits"],"prefix":"10.3390","volume":"5","author":[{"given":"Alfred","family":"Corey","sequence":"first","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi-Sau","family":"Migone","sequence":"additional","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Bolmer","sequence":"additional","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Fiscella","sequence":"additional","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Ward","sequence":"additional","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecil","family":"Chen","sequence":"additional","affiliation":[{"name":"Human Genome Sciences, Inc., 14200 Shady Grove Road, Rockville, MD 20850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Meister","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center, 505 King Ave., JM-7, Columbus, OH 43201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,1,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: A century of inhalational anthrax cases from 1900 to 2005","volume":"144","author":"Holty","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: Updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0014-5793(02)03609-8","article-title":"Anthrax toxin: A tripartite lethal combination","volume":"531","author":"Ascenzi","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"ref_6","first-page":"691","article-title":"Pathology of experimental inhalation anthrax in the rhesus monkey","volume":"73","author":"Fritz","year":"1995","journal-title":"Lab. Invest."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1354\/vp.44-5-716","article-title":"Pathology of inhalational anthrax infection in the African green monkey","volume":"44","author":"Twenhafel","year":"2007","journal-title":"Vet. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.LAB.0000080599.43791.01","article-title":"Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)","volume":"83","author":"Vasconcelos","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_9","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"Zaucha","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalational anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1128\/AAC.00090-06","article-title":"Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model","volume":"50","author":"Kao","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/430708","article-title":"A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteer","volume":"41","author":"Subramanian","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/clpt.2008.23","article-title":"Animal studies in the development of medical countermeasures","volume":"83","author":"Roberts","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2004.08.007","article-title":"Production and purification of Bacillus anthracis protective antigen from Escherichia coli","volume":"38","author":"Laird","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/IAI.00792-06","article-title":"Protective antigen as a correlative marker for anthrax in animal models","volume":"74","author":"Kobiler","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_17","unstructured":"Corey, A., and Migone, T. (2007, January 24-27). Serum Protective Antigen Kinetics in the Rabbit Model of Inhalational Anthrax. Proceedings of National Biotechnology Conference, San Diego, CA, USA."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.18.1.1","article-title":"The gompertz curve as a growth curve","volume":"18","author":"Winsor","year":"1932","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/aem.56.6.1875-1881.1990","article-title":"Modeling of the bacterial growth curve","volume":"56","author":"Zwietering","year":"1990","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3168\/jds.S0022-0302(03)73780-1","article-title":"Effects of carbon dioxide on bacterial growth parameters in milk as measured by conductivity","volume":"86","author":"Martin","year":"2003","journal-title":"J. Dairy Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2621.2000.tb10614.x","article-title":"Inoculum size of Clostridium botulinum 56A spores influences time-to-detection and percent growth-positive samples","volume":"65","author":"Zhao","year":"2000","journal-title":"J. Food Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1128\/am.28.5.831-835.1974","article-title":"Diauxic growth of Propionibacterium shermanii","volume":"28","author":"Lee","year":"1974","journal-title":"Appl. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1432-0436.1981.tb01173.x","article-title":"A theoretical equation for diauxic growth and its application to the kinetics of the early development of the sea urchin embryo","volume":"20","author":"Liquori","year":"1981","journal-title":"Differentiation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.287.7.863","article-title":"Fatal inhalation anthrax in a 94-year-old Connecticut woman","volume":"287","author":"Barakat","year":"2002","journal-title":"JAMA"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/5\/1\/120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:44:15Z","timestamp":1760219055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/5\/1\/120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"alternative-id":["toxins5010120"],"URL":"https:\/\/doi.org\/10.3390\/toxins5010120","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,14]]}}}